Pharma Focus Europe

Home
India
Hyderabad
Pharma Focus Europe

Welcome to Pharmafocus Europe! Stay updated with the latest in European pharmaceuticals, innovations, and industry news. Ltd..

Join our community for insights and discussions on advancing healthcare. https://www.linkedin.com/company/pharmafocuseurope/ About Pharma Focus Europe:
Pharma Focus Europe is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the world’s leading pharmaceutical companies. Pharma Focus Europe covers important issues and trends shaping the future of the pharma industry across Europe and rest of the world. Pharma Focus Europe offers . . .
• Dedicated, reliable and accurate coverage of the industry’s progress and
• Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:
• Strategy
• Research and Development
• Manufacturing
• Clinical Trials
• Information Technology

The one-stop pharma destination www.pharmafocuseurope.com features complete content from the Pharma Focus Europe magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership
The magazine’s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on Europe, Pharma Focus Europe reaches out to the key industry leaders across Europe, Asia and the Americas.

09/03/2026

In the pharmaceutical industry, trust is everything.

Healthcare professionals and decision-makers don’t respond to traditional promotions the way they used to. Instead, they look for 𝐫𝐞𝐥𝐢𝐚𝐛𝐥𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧, 𝐞𝐱𝐩𝐞𝐫𝐭 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐚𝐧𝐝 𝐫𝐞𝐚𝐥-𝐰𝐨𝐫𝐥𝐝 𝐫𝐞𝐬𝐮𝐥𝐭𝐬 before considering new partnerships or solutions.

That’s where 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 comes in.

Our latest article breaks down 𝐟𝐢𝐯𝐞 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐟𝐨𝐫𝐦𝐚𝐭𝐬 𝐭𝐡𝐚𝐭 𝐩𝐡𝐚𝐫𝐦𝐚 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐚𝐫𝐞 𝐮𝐬𝐢𝐧𝐠 𝐭𝐨 𝐛𝐮𝐢𝐥𝐝 𝐜𝐫𝐞𝐝𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝐡𝐢𝐠𝐡-𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐥𝐞𝐚𝐝𝐬:

✔ Webinars for expert-driven discussions
✔ Whitepapers for in-depth research and insights
✔ Case studies that show real results
✔ Thought leadership articles that share industry perspectives
✔ Account-based marketing content for targeted engagement

Each of these formats helps organizations educate audiences while building stronger relationships with healthcare stakeholders.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐡𝐞𝐫𝐞:
https://www.pharmafocuseurope.com/articles/top-pharma-content-formats-engagement-leads

06/03/2026

Maintaining 𝐜𝐥𝐞𝐚𝐧 𝐚𝐧𝐝 𝐬𝐭𝐚𝐛𝐥𝐞 𝐢𝐧𝐜𝐮𝐛𝐚𝐭𝐢𝐨𝐧 conditions is essential for successful cell culture workflows in pharmaceutical and biotech labs.

Daily incubator shaker use can introduce 𝐚𝐢𝐫𝐛𝐨𝐫𝐧𝐞 𝐜𝐨𝐧𝐭𝐚𝐦𝐢𝐧𝐚𝐭𝐢𝐨𝐧 𝐫𝐢𝐬𝐤𝐬, potentially affecting experiment reproducibility and lab productivity. Continuous HEPA air filtration during active incubation helps maintain air quality and protect sensitive cultures.

𝐎𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐛𝐥𝐨𝐠 𝐚𝐧𝐝 𝐨𝐧-𝐝𝐞𝐦𝐚𝐧𝐝 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 𝐞𝐱𝐩𝐥𝐚𝐢𝐧 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠:

✔ How contamination risk occurs during routine shaker operation
✔ Why continuous air filtration matters during incubation
✔ When enhanced contamination control can improve lab workflows
✔ How performance was tested in real laboratory conditions

The article also includes an application note explaining how continuous HEPA filtration integrated into the Multitron Incubator Shaker supports reliable incubation environments.

𝐖𝐚𝐭𝐜𝐡 𝐭𝐡𝐞 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 𝐚𝐧𝐝 𝐫𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐛𝐥𝐨𝐠:
https://industry.pharmafocuseurope.com/clientemailblast/1772622711-Infors-HT-2026.html

05/03/2026

B-cells are rapidly emerging as powerful drivers of next-generation immunotherapy.

Traditional treatments relied on 𝐛𝐫𝐨𝐚𝐝 𝐁-𝐜𝐞𝐥𝐥 𝐝𝐞𝐩𝐥𝐞𝐭𝐢𝐨𝐧, but new research is moving toward 𝐚𝐧𝐭𝐢𝐠𝐞𝐧-𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐁-𝐜𝐞𝐥𝐥 𝐦𝐨𝐝𝐮𝐥𝐚𝐭𝐢𝐨𝐧—a more precise strategy that could improve safety while maintaining protective immunity.

In the latest 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 𝐈𝐬𝐬𝐮𝐞 𝟎𝟕,
experts Daniel‑Paul Bednarík , Kristi Jones, and Mathias Oelke highlight how engineered B-cells, regulatory B-cells, and in-vivo manipulation could reshape therapies across cancer, infectious diseases, and autoimmune disorders.

The article also examines:
✔ How B-cells influence tumor immunity
✔ The promise of engineered B-cells for long-lasting antibody production
✔ The future of antigen-specific immune tolerance in autoimmune diseases

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐚𝐫𝐭𝐢𝐜𝐥𝐞:
https://www.pharmafocuseurope.com/biopharma/the-emerging-role-of-b-cells-in-immunotherapy

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 𝐈𝐬𝐬𝐮𝐞 𝟎𝟕 𝐞𝐁𝐨𝐨𝐤 𝐧𝐨𝐰:
https://www.pharmafocuseurope.com/magazine

04/03/2026

Alzheimer’s care is evolving.

Polymeric nanoparticles combined with stem cells may help treat 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫’𝐬 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 at the cellular level—reducing plaques, promoting neuron regeneration, and improving memory function.

A new era of regenerative therapy is emerging.

𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐨𝐝𝐚𝐲:
https://www.pharmafocuseurope.com/articles/therapeutic-intervention-of-polymeric-nanoparticles-combining-bone-marrow-stem-cells

03/03/2026

𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭𝐬 𝐝𝐞𝐦𝐚𝐧𝐝 𝐦𝐨𝐫𝐞 𝐭𝐡𝐚𝐧 𝐛𝐫𝐨𝐚𝐝 𝐦𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 𝐜𝐚𝐦𝐩𝐚𝐢𝐠𝐧𝐬.

From centralized approvals via the European Medicines Agency to GDPR compliance and country-specific procurement systems, B2B pharma marketers must prioritize precision targeting and ROI-driven strategies.

𝐖𝐡𝐚𝐭’𝐬 𝐰𝐨𝐫𝐤𝐢𝐧𝐠 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞 𝐫𝐢𝐠𝐡𝐭 𝐧𝐨𝐰?

✔ Account-Based Marketing (ABM)
✔ EU regulatory-focused content
✔ Consent-driven lead capture
✔ Localized campaigns in German & French markets
✔ Multi-channel engagement (LinkedIn + industry platforms + events)
✔ Sustainability & ESG positioning

In pharma B2B, one high-value contract can outperform thousands of generic leads. The question is no longer “How many leads?” — it’s “How much revenue?”

Ready to elevate your European pharma strategy?

𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞:
https://www.pharmafocuseurope.com/articles/b2b-lead-generation-pharma-eu-markets

27/02/2026

The future of medicine is getting personal—and precise. Targeted protein degradation is revolutionizing treatment by removing disease-causing proteins, not just blocking them.

PROTACs handle intracellular targets, while LYTACs go after extracellular proteins, offering hope for previously “undruggable” diseases.

Learn how these innovations could transform therapies in cancer, autoimmune disorders, and more.

𝐆𝐞𝐭 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐬𝐭𝐨𝐫𝐲 𝐚𝐧𝐝 𝐬𝐭𝐚𝐲 𝐚𝐡𝐞𝐚𝐝 𝐢𝐧 𝐩𝐡𝐚𝐫𝐦𝐚 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: https://www.pharmafocuseurope.com/articles/harnessing-the-intracellular-machinery-to-degrade-cellular-proteins

26/02/2026

Cancer therapy is evolving — and plant-based nanoparticles are part of the conversation.

Plant-derived edible nanoparticles (PDENPs) offer targeted drug delivery, low toxicity, and promising anti-inflammatory and anti-tumor effects. Researchers are studying their role in improving chemotherapy outcomes while minimizing harm to healthy cells.

Could this be the future of sustainable cancer treatment?

Learn more here: https://www.pharmafocuseurope.com/articles/plant-derived-edible-nanoparticles-in-delivering-cancer-drugs-fact-or-fad

25/02/2026

𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐛𝐨𝐰𝐞𝐥 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 affects millions worldwide — and treatment costs continue to rise.

Conditions like Crohn's disease and Ulcerative colitis are driven by immune imbalance. While biologics such as Stelara and anti-TNF therapies have transformed care, researchers are also investigating spleen-derived cytokine complexes as a supportive immune-modulating strategy.

𝐖𝐡𝐲 𝐭𝐡𝐢𝐬 𝐦𝐚𝐭𝐭𝐞𝐫𝐬:

• Supports macrophage and T-cell regulation
• May promote mucosal healing
• Demonstrated ulcer improvement in preclinical and veterinary settings
• Potentially more accessible manufacturing models

As the industry shifts toward early remission and long-term disease control, immune correction strategies could reshape the IBD landscape.

𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐞𝐯𝐨𝐥𝐯𝐢𝐧𝐠 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐜𝐨𝐧𝐜𝐞𝐩𝐭 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞.
https://www.pharmafocuseurope.com/articles/spleen-cytokines-against-inflammatory-bowel-disease

24/02/2026

Regulations are evolving — pharma leaders must stay ahead.

𝐁𝟐𝐁 𝐩𝐡𝐚𝐫𝐦𝐚 𝐰𝐞𝐛𝐢𝐧𝐚𝐫𝐬 provide expert-led regulatory insights, compliance strategies, audit readiness guidance, and cross-border alignment updates.

With agencies like the U.S. Food and Drug Administration and European Medicines Agency shaping global standards, proactive learning reduces risk and speeds approvals.

Strengthen your regulatory strategy today.

𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.pharmafocuseurope.com/articles/b2b-pharma-webinars-regulatory-insights

20/02/2026

Crying over product loss after freezing? It may be cryoconcentration at work.

Uncontrolled freezing of biologics can lead to protein instability and costly batch quarantine. A well-designed cold chain ensures product quality, safety, and consistent yield—no matter the single-use container.

Control it before you lose it.

𝐋𝐞𝐚𝐫𝐧 𝐡𝐨𝐰 𝐭𝐨 𝐩𝐫𝐨𝐭𝐞𝐜𝐭 𝐲𝐨𝐮𝐫 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬:
https://industry.pharmafocuseurope.com/clientemailblast/1771390451-Single-Use-Support-GmBH.html

19/02/2026

𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 brings you the latest in pharma—from insightful articles and interviews to research breakthroughs, tech trends, and industry news. Perfect for pharma professionals, researchers, and decision-makers looking to stay informed and connected.

https://industry.pharmafocuseurope.com/e-newsletters/1771320498-Pharma-Focus-Europe-Feb-26.html

𝐒𝐭𝐚𝐲 𝐢𝐧𝐟𝐨𝐫𝐦𝐞𝐝, 𝐬𝐭𝐚𝐲 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞:

𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐧𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 𝐭𝐨𝐝𝐚𝐲 𝐚𝐧𝐝 𝐬𝐡𝐚𝐫𝐞 𝐰𝐢𝐭𝐡 𝐲𝐨𝐮𝐫 𝐜𝐨𝐥𝐥𝐞𝐚𝐠𝐮𝐞𝐬! https://www.pharmafocuseurope.com/e-newsletter-subscribe

18/02/2026

Biologics manufacturing is complex—and fragmented supply chains only add more risk.

Integrated solutions are helping pharma companies reduce delays, improve compliance, and accelerate time to market.

The new large-scale facility in Stein, Switzerland strengthens global biologics supply by combining drug substance and drug product capabilities under one coordinated network. Supporting vial, prefilled syringe (PFS), and cartridge formats with GMP Annex 1 alignment, automation, and sustainability at their core.

With more than 50 tech transfers completed in the past year, proven expertise makes scaling biologics more predictable and efficient.

Want to see how an integrated CDMO model reduces risk and improves speed?

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐐&𝐀 𝐧𝐨𝐰: https://industry.pharmafocuseurope.com/clientemailblast/1771219335-Lonza-Integrated-Biologics.html

Address

111, 112 First Floor, Block 2, White House
Hyderabad
500016

Website

http://pharmafocuseurope.com/

Alerts

Be the first to know and let us send you an email when Pharma Focus Europe posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Hyderabad?